Stevanato Group, a global provider of integrated containment and delivery solutions to the biopharmaceutical and life sciences industries, has launched an Artificial Intelligence (AI) platform, based on Deep Learning (DL) models, that leverages the benefits of human-like decision-making in automatic visual inspection equipment. The platform allows pharma companies to overcome the traditional trade-off between detection rate and false rejection rate, ensuring robust and replicable results. False ...